SCHEMBL9165252

SCHEMBL9165252

CCCCCCCCCCCCCCOC(=O)c1cc(C(=O)OCCCCCCCCCCCCCC)cc(N(CC(=O)OCc2ccccc2)CC(=O)OCc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ CYP3A4 P08684 2/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ CNR2 P34972 1/20 0.50
▸ ESR1 P03372 3/20 0.47
▸ AKR1C4 P17516 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.47
▸ AKR1C1 Q04828 1/20 0.47
▸ LMNA P02545 2/20 0.47
▸ TP53 P04637 1/20 0.45
▸ PLA2G2A P14555 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9170618 0.86 PLA2G2A (0.53) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL9163857 0.84 PLA2G2A (0.65) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL9170924 0.82 CETP (0.45) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL9163827 0.82 PLA2G2A (0.54) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL9166194 0.82 PLA2G2A (0.64) TSHRALDH1A1CNR2ESR1AKR1C4
SCHEMBL9165915 0.82 PLA2G2A (0.64) TSHRALDH1A1CNR2ESR1AKR1C4
SCHEMBL9166922 0.82 PLA2G2A (0.64) TSHRALDH1A1CNR2ESR1AKR1C4
SCHEMBL9172248 0.81 PLA2G2A (0.61) CNR2PLA2G2ABLM
SCHEMBL11297076 0.81 TDP1 (0.64) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL2845847 0.81 TDP1 (0.64) TSHRALDH1A1CYP3A4MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5446189-A Diester intermediates for diacid enzyme inhibitor HOFFMANN-LA ROCHE INC. (US) 1995-08-29 — — US disclosed
US-5324747-A Treatment of inflammatory diseases HOFFMANN-LA ROCHE INC. (US) 1994-06-28 — — US disclosed
EP-0579066-A2 N-substituted anilines F. HOFFMANN-LA ROCHE AG (CH) 1994-01-19 — — EP disclosed
Send feedback